跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bortebin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bortebin
Approved
STANDARD
Bortebin
Eugia Pharma Specialties Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c6ab1a73f945408a
Company
Eugia Pharma Specialties Limited
Type
Standard
Approval Details
Approval Id
c6ab1a73f945408a
Drug Approval Philippines Name
Bortebin
Product Name
Bortebin
Registration Number
DRP-10645
Brand Name
Bortebin
Generic Name
Bortezomib
Dosage Form
Lyophilized Powder for Injection (S.C./1.V.)
Dosage Strength
3.5 mg
Manufacturer
Eugia Pharma Specialties Limited
Importer
Medethix, Inc.
Distributor
I.E. Medica, Inc.
Issuance Date
28 October 2021
Expiry Date
28 October 2026
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c6ab1a73f945408a
Type
Standard
Back to Philippines FDA Approvals